Clik here to view.
PENTAX Europe GmbH Appoints Rainer Burkard President of Europe, Middle East...
HAMBURG, Germany PENTAX Europe GmbH, a division of HOYA Corporation, announced the appointment of Mr. Rainer Burkard to the position of President Europe, Middle East and Africa (EMEA) as of 1st...
View ArticleClik here to view.
Gynesonics Announces New CPT Code Established for Sonata™ System
REDWOOD CITY, Calif. Gynesonics, a women’s healthcare company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, today announced that the American Medical...
View ArticleClik here to view.
Mevion Medical Systems Forming Joint Venture in China and Secures up to...
LITTLETON, Mass. Mevion Medical Systems, the leading provider of advanced proton therapy systems, announced today that it has entered into an investment agreement where up to $200 million will be...
View ArticleClik here to view.
Cold Genesys Secures Series B Investment for Pivotal and Combo Immunotherapy...
SANTA ANA, Calif. Cold Genesys Inc., a clinical-stage oncolytic immunotherapy company, today announced the successful completion of a Series B financing co-led by Ally Bridge Group and WI Harper...
View ArticleClik here to view.
GenomiCare Partners with N-of-One to Provide High-quality Clinical...
LEXINGTON, Mass. & SHANGHAI N-of-One, Inc., the global leader in clinical interpretation for precision medicine in oncology, and GenomiCare Biotechnology, a fast-growing precision medicine...
View ArticleClik here to view.
APCER Life Sciences Appoints Dr. Sutinder Bindra as Global Head of Medical...
PRINCETON, N.J. APCER Life Sciences, the truly global provider of safety, medical, regulatory, and technology services, announced today that Sutinder Bindra, MD, has joined the company as Global...
View ArticleClik here to view.
Sosei Subsidiary Heptares and AstraZeneca Enter Agreement to Develop Novel...
TOKYO Sosei Group Corporation (TOKYO:4565) is pleased to announce that its wholly-owned subsidiary Heptares Therapeutics (“Heptares”) and AstraZeneca have entered into a licensing agreement under...
View ArticleClik here to view.
Dr. Reddy’s Announces Strategic Collaboration with Amgen in India
HYDERABAD, India Dr. Reddy’s Laboratories Ltd. (NYSE: RDY) today announced that it has entered into a strategic collaboration with Amgen – one of the world’s leading independent biotechnology...
View ArticleClik here to view.
Chiltern宣布同意收购Theorem Clinical Research
伦敦和北卡罗莱纳州威尔明顿 (美国商业资讯)–领先的全球性合同研究组织(CRO) Chiltern宣布已签署一份收购协议，收购另一家领先的全球性CRO Theorem Clinical Research。 Chiltern首席执行官Jim...
View ArticleClik here to view.
Chiltern Announces Agreement to Acquire Theorem Clinical Research
LONDON & WILMINGTON, N.C. Chiltern, a leading global contract research organization (CRO), announced it has signed a purchase agreement to acquire Theorem Clinical Research, another leading...
View ArticleClik here to view.
チルターンがセオレム・クリニカル・リサーチの買収契約を発表
ロンドン & 米ノースカロライナ州ウィルミントン （ビジネスワイヤ） — 世界的大手医薬品開発業務受託機関（CRO）のチルターンは、別の世界的大手CROのセオレム・クリニカル・リサーチを買収する契約を締結したと発表しました。 チルターン最高経営責任者（CEO）のJim...
View ArticleTaro Provides Results for Quarter Ended June 2015
HAWTHORNE, N.Y. Taro Pharmaceutical Industries Ltd. (NYSE:TARO) (“Taro” or the “Company”) today provided unaudited financial results for the quarter ended June 30, 2015. Quarter ended June 30, 2015...
View ArticleClik here to view.
Cold Genesys的枢纽性和联合免疫疗法试验获得B轮投资
加州圣安娜 (美国商业资讯)–临床阶段溶瘤免疫疗法公司Cold Genesys Inc.今天宣布成功完成一笔B轮融资，该融资由Ally Bridge集团和WI Harper集团共同主导，Whitesun Healthcare Ventures和Song Hong Fang也参与其中。该笔内部人士发起的B轮融资为1000万美元，将用于推动Cold...
View ArticleClik here to view.
Clik here to view.
Extension Study Data Supporting Long-Term Safety and Efficacy of Eloctate®...
CAMBRIDGE, Mass. & STOCKHOLM Newly published clinical data demonstrate that people on extended-interval prophylaxis regimens with ELOCTATE® [Antihemophilic Factor (Recombinant), Fc Fusion...
View ArticleClik here to view.
FortuneRock (China) Co., Ltd. Announces Initial Public Offering (IPO) on...
BEIJING FortuneRock (China) Co., Ltd., a biotechnology and biopharmaceutical company, announced that it has received approval for its initial public offering and listing on the National Equities...
View ArticleClik here to view.
Macrogen Launches Special Promotion on Exome Sequencing
SEOUL, South Korea The precision medicine biotech company Macrogen (CEO Chong Hyon-yong, www.macrogen.com) (KOSDAQ:038290), announced on August 10th that it is launching a special promotion on exome...
View ArticleClik here to view.
Asterand Bioscience Acquires AdeptBio LLC
DETROIT Asterand Bioscience, Inc. is pleased to announce the acquisition of AdeptBio LLC, a Memphis-based biobank organization, which specializes in procurement of human tissue specimens. “We are...
View ArticleClik here to view.
ResolutionMD® Medical Imaging Software Now Registered for Web and Mobile...
CALGARY, Alberta Calgary Scientific Inc., a company known for creating innovative technology for the medical industry and beyond, announced today that ResolutionMD® medical imaging software is now...
View ArticleClik here to view.
Dr. Reddy’s Announces the Launch of PRAMIPEXOLE Dihydrochloride...
HYDERABAD, India Dr. Reddy’s Laboratories (NYSE: RDY) announced today that it has launched PRAMIPEXOLE dihydrochloride extended-release tablets 0.375 mg, 0.75 mg, 1.5 mg, 3 mg and 4.5 mg, a...
View Article